Transport of topoisomerase 1 inhibitors by the breast cancer resistance protein. Potential clinical implications

J.H.M. Schellens, M. Maliepaard, R.J. Scheper, G.L. Scheffer, J.W. Jonker, J.H. Beijnen, A.H. Schinkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)188-194
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume922
Publication statusPublished - 2000

Cite this